Sujal M Patel Nautilus Biotechnology, Inc. (NAUT) insider trading activity

NAUT Quotes by TradingView

Sujal M Patel is CEO, President, and Secretary of Nautilus Biotechnology, Inc.. Currently has a direct ownership of 10.3 Million shares of NAUT, which is worth approximately $14.3 Million. The most recent transaction as insider was on Sep 08, 2025, when has been sold 83,500 shares (Common Stock) at a price of $0.68 per share, resulting in proceeds of $56,780. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.3M
1.97% 3M change
2.75% 12M change
Total Value Held $14.3 Million

Sujal M Patel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 08 2025
BUY
Open market or private purchase
$56,780 $0.68 p/Share
83,500 Added 0.8%
10,341,721 Common Stock
Sep 05 2025
BUY
Open market or private purchase
$78,055 $0.67 p/Share
116,500 Added 1.12%
10,258,221 Common Stock
Mar 20 2025
BUY
Open market or private purchase
$23,933 $1.0 p/Share
23,933 Added 0.24%
10,141,721 Common Stock
Mar 19 2025
BUY
Open market or private purchase
$52,767 $0.99 p/Share
53,300 Added 0.52%
10,117,788 Common Stock
Mar 11 2024
BUY
Open market or private purchase
$34,204 $2.84 p/Share
12,044 Added 0.12%
10,064,488 Common Stock
Mar 08 2024
BUY
Open market or private purchase
$7,265 $2.99 p/Share
2,430 Added 0.02%
10,052,444 Common Stock
Mar 07 2024
BUY
Open market or private purchase
$54,488 $2.89 p/Share
18,854 Added 0.19%
10,050,014 Common Stock
Mar 06 2024
BUY
Open market or private purchase
$25,020 $2.7 p/Share
9,267 Added 0.09%
10,031,160 Common Stock
Mar 05 2024
BUY
Open market or private purchase
$19,623 $2.65 p/Share
7,405 Added 0.07%
10,021,893 Common Stock
Aug 08 2022
BUY
Open market or private purchase
$24,454 $2.93 p/Share
8,346 Added 0.08%
10,014,488 Common Stock
Aug 05 2022
BUY
Open market or private purchase
$121,630 $2.92 p/Share
41,654 Added 0.41%
10,006,142 Common Stock
May 09 2022
BUY
Open market or private purchase
$198,000 $3.96 p/Share
50,000 Added 0.5%
9,964,488 Common Stock
Mar 04 2022
BUY
Exercise of conversion of derivative security
$1,000 $10.0 p/Share
100 Added 0.0%
9,914,488 Common Stock
Mar 03 2022
BUY
Open market or private purchase
$180,000 $3.6 p/Share
50,000 Added 0.5%
9,914,388 Common Stock
Dec 01 2021
BUY
Open market or private purchase
$416,344 $4.73 p/Share
88,022 Added 0.88%
9,864,388 Common Stock
Nov 30 2021
BUY
Open market or private purchase
$764,536 $4.72 p/Share
161,978 Added 1.63%
9,776,366 Common Stock
SMP

Sujal M Patel

CEO, President, and Secretary
Seattle, WA

Track Institutional and Insider Activities on NAUT

Follow Nautilus Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAUT shares.

Notify only if

Insider Trading

Get notified when an Nautilus Biotechnology, Inc. insider buys or sells NAUT shares.

Notify only if

News

Receive news related to Nautilus Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NAUT